Targeting VGLUT2 in Mature Dopamine Neurons Decreases Mesoaccumbal Glutamatergic Transmission and Identifies a Role for Glutamate Co-release in Synaptic Plasticity by Increasing Baseline AMPA/NMDA Ratio

Eitemau Tebyg

• Midbrain Gene Screening Identifies a New Mesoaccumbal Glutamatergic Pathway and a Marker for Dopamine Cells Neuroprotected in Parkinson’s Disease
  gan: Viereckel, Thomas, et al.
  Cyhoeddwyd: (2016)
• Selective Knockout of the Vesicular Monoamine Transporter 2 (Vmat2) Gene in Calbindin2/Calretinin-Positive Neurons Results in Profound Changes in Behavior and Response to Drugs of Abuse
  gan: König, Niclas, et al.
  Cyhoeddwyd: (2020)
• Neurocircuitry of Reward and Addiction: Potential Impact of Dopamine–Glutamate Co-release as Future Target in Substance Use Disorder
  gan: Bimpisidis, Zisis, et al.
  Cyhoeddwyd: (2019)
• A model of cooperative effect of AMPA and NMDA receptors in glutamatergic synapses
  gan: Di Maio, Vito, et al.
  Cyhoeddwyd: (2016)
• Genetic inactivation of the vesicular glutamate transporter 2 (VGLUT2) in the mouse: What have we learnt about functional glutamatergic neurotransmission?
  gan: Wallén-Mackenzie, Åsa, et al.
  Cyhoeddwyd: (2010)